These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 25769430)
1. Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1. Hoshino Y; Nishida J; Katsuno Y; Koinuma D; Aoki T; Kokudo N; Miyazono K; Ehata S Am J Pathol; 2015 May; 185(5):1457-70. PubMed ID: 25769430 [TBL] [Abstract][Full Text] [Related]
2. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β. Katsuno Y; Ehata S; Yashiro M; Yanagihara K; Hirakawa K; Miyazono K J Pathol; 2012 Nov; 228(3):391-404. PubMed ID: 22430847 [TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655 [TBL] [Abstract][Full Text] [Related]
4. Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling. Fullerton PT; Creighton CJ; Matzuk MM Mol Endocrinol; 2015 Oct; 29(10):1440-53. PubMed ID: 26284758 [TBL] [Abstract][Full Text] [Related]
5. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973 [TBL] [Abstract][Full Text] [Related]
6. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer. Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934 [TBL] [Abstract][Full Text] [Related]
7. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis. Yasutome M; Gunn J; Korc M Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109 [TBL] [Abstract][Full Text] [Related]
8. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta. Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526 [TBL] [Abstract][Full Text] [Related]
9. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis. Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872 [TBL] [Abstract][Full Text] [Related]
10. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401 [TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay. Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744 [TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022 [TBL] [Abstract][Full Text] [Related]
13. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs. Lin SZ; Xu JB; Ji X; Chen H; Xu HT; Hu P; Chen L; Guo JQ; Chen MY; Lu D; Wang ZH; Tong HF Mol Med Rep; 2015 Oct; 12(4):5865-71. PubMed ID: 26238071 [TBL] [Abstract][Full Text] [Related]
14. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer. Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426 [TBL] [Abstract][Full Text] [Related]
15. Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells. Zhao S; Ammanamanchi S; Brattain M; Cao L; Thangasamy A; Wang J; Freeman JW J Biol Chem; 2008 Apr; 283(17):11293-301. PubMed ID: 18310076 [TBL] [Abstract][Full Text] [Related]
16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325 [TBL] [Abstract][Full Text] [Related]
17. Endoglin (CD105) and SMAD4 regulate spheroid formation and the suppression of the invasive ability of human pancreatic cancer cells. Kokaji E; Shimomura A; Minamisaka T; Nakajima T; Miwa S; Hatta H; Nishida T; Kiya C; Imura J Int J Oncol; 2018 Mar; 52(3):892-900. PubMed ID: 29393426 [TBL] [Abstract][Full Text] [Related]